EAU & ASCO: Penile Cancer 2023: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
Line 438: | Line 438: | ||
** '''Additional staging is warranted''' | ** '''Additional staging is warranted''' | ||
** initial LN staging is focused on identifying (micro)metastatic disease in the inguinal LNs as early as possible | ** initial LN staging is focused on identifying (micro)metastatic disease in the inguinal LNs as early as possible | ||
===== Staging ===== | |||
====== Non-surgical staging ====== | |||
* Imaging | |||
** Not reliable to evaluate clinically node-negative patients | |||
*** Conventional imaging modalities such as US, computed tomography (CT) or MRI cannot detect micrometastases | |||
***18F-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG-PET) does not detect LN metastases < 10 mm | |||
***These imaging modalities can be of value to detect enlarged/abnormal nodes in patients when physical examination is challenging (e.g., due to obesity). | |||
====== Surgical staging ====== | |||
* Invasive/surgical staging remains indispensable to identify micro-metastasis before nodal metastases become palpable/visible. | |||
* '''Indications''' | |||
** '''Recommended''' | |||
*** '''High-risk tumors: T1b or higher''' | |||
** Optional for intermediate-risk (pT1a G2) | |||
*** Surveillance is an alternative to surgical staging in patients willing to comply with strict follow-up | |||
* '''Options''' | |||
** '''Dynamic sentinel node biopsy (DSNB) (preferred)''' | |||
*** Developed to avoid resecting unnecessary LNs and thereby minimizing the morbidity of surgical staging | |||
*** A sentinel node (SN) is defined as the first LN on a direct drainage pathway from the primary tumour. | |||
**** Based on this concept, it is assumed that if the SN is negative, this indicates the absence of lymphatic tumour spread in the corresponding inguinal basin. In case histopathology identifies SN (micro)metastasis, ipsilateral completion ILND is indicated | |||
*** High diagnostic accuracy and low complication rates, especially when performed in experienced centres (sensitivity 92–96%, false negative rates 4–8%, complication rate 6–14%) | |||
*** '''Technique''' | |||
**** '''Inguinal US is obtained prior to DSNB''' | |||
***** If sonographically suspicious nodes are detected, fine needle aspiration cytology (FNAC) can easily be performed in the same session to confirm the diagnosis of inguinal LN metastasis | |||
****** if US + FNAC is positive, it can reduce the need for DSNB and allow for additional staging and therapeutic LN dissection at an earlier stage | |||
***If DSNB is not available, and referral to a centre with experience with DSNB is not feasible, or if the patient does not want to run the risk of a false-negative procedure, ILND (modified/superficial/video-endoscopic) can be considered after informing the patient of the inherent risk of higher morbidity associated with these procedures. | |||
** Inguinal lymph node dissection (ILND) | |||
*** Radical inguinal lymph node dissection (ILND) is the most accurate surgical staging method, but is associated with the highest complication rates | |||
*** Modified ILND lowers morbidity while maintaining sufficient sensitivity | |||
**** Modifications in modified ILND | |||
***** Shorter skin incision | |||
***** No dissection lateral to the femoral artery | |||
***** No dissection caudal to the fossa ovalis | |||
***** Preservation of the saphenous vein | |||
***Video-endoscopic/robot-assisted radical LND has been introduced more recently | |||
****Similar lymph node yield compared to open | |||
****Reduces wound-related complications compared to open ILND, but no significant reduction in lymphatic complications | |||
*****Main predictor of lymphatic complications is the number of lymph nodes removed | |||
==== Clinically node-positive patients (cN+) ==== | ==== Clinically node-positive patients (cN+) ==== |